SI-BONE, Inc. (NASDAQ: SIBN) AI-Powered Stock Analysis
See how SI-BONE, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
SIBN●NASDAQ
HealthcareMedical - Devices
$18.95
$0.05(0.26%)
U.S. Market opens in 3h 2m
SI-BONE, Inc. (NASDAQ: SIBN) AI-Powered Stock Analysis
See how SI-BONE, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerSI-BONE, Inc. (NASDAQ: SIBN) Stock Overall Grade
SI-BONE, Inc.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to SI-BONE, Inc.'s overall NASDAQ stock rating.
Forecast
BScore
64/100Financial Growth
A+Score
100/100Fundamental Growth
C+Score
55/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
B+Score
75/100SI-BONE, Inc. (NASDAQ: SIBN) AI-Powered Stock Analysis
On the NASDAQ, SIBN demonstrates Good performance with an overall Forecast Score of 64/100 (B), reflecting high confidence in its potential. Financial Growth (100/100, A+) and Fundamental Growth (55/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (75/100, B+) suggests High divergence in outlook.(NASDAQ: SIBN) Component Analysis Explained
Understand the key factors behind each SI-BONE, Inc. (NASDAQ: SIBN) stock grade, including financials, comparisons, and forecasts.